320 related articles for article (PubMed ID: 26376814)
21. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
22. Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata.
Celik SD; Ates O
J Clin Lab Anal; 2018 Jun; 32(5):e22386. PubMed ID: 29349811
[TBL] [Abstract][Full Text] [Related]
23. Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia.
Ali YB; Foad RM; Abdel-Wahed E
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3245-3250. PubMed ID: 29286214
[TBL] [Abstract][Full Text] [Related]
24. The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study.
Imboden M; Nicod L; Nieters A; Glaus E; Matyas G; Bircher AJ; Ackermann-Liebrich U; Berger W; Probst-Hensch NM;
Clin Exp Allergy; 2006 Feb; 36(2):211-8. PubMed ID: 16433859
[TBL] [Abstract][Full Text] [Related]
25. Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease.
Liu W; Tang Q; Jiang H; Ding X; Liu Y; Zhu R; Tang Y; Li B; Wei M
Angiology; 2009; 60(2):180-5. PubMed ID: 18599493
[TBL] [Abstract][Full Text] [Related]
26. PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
Guru SA; Mir R; Bhat M; Najar I; Zuberi M; Sumi M; Masroor M; Gupta N; Saxena A
Tumour Biol; 2017 Oct; 39(10):1010428317713857. PubMed ID: 29019285
[TBL] [Abstract][Full Text] [Related]
27. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
[TBL] [Abstract][Full Text] [Related]
28. Protective role of IL-18 -137G/C polymorphism in a North Indian population with asthma: a pilot study.
Birbian N; Singh J; Jindal SK
Cytokine; 2013 Jan; 61(1):188-93. PubMed ID: 23085113
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-18 promoter polymorphisms in patients with Behçet's disease.
Lee YJ; Kang SW; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Hum Immunol; 2006 Oct; 67(10):812-8. PubMed ID: 17055358
[TBL] [Abstract][Full Text] [Related]
30. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of the human Ha-ras oncogene locus in chronic lymphocytic and chronic myelogenous leukemia.
Knauf WU; Ho AD
Hematol Oncol; 1991; 9(3):157-62. PubMed ID: 1682229
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-18 promoter polymorphisms and risk of idiopathic recurrent pregnancy loss in a Tunisian population.
Messaoudi S; Dandana M; Magdoud K; Meddeb S; Ben Slama N; Hizem S; Mahjoub T
J Reprod Immunol; 2012 Mar; 93(2):109-13. PubMed ID: 22386125
[TBL] [Abstract][Full Text] [Related]
34. HLA system affects the age-at-onset in chronic myeloid leukemia.
Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic Leukemia in Sudanese Population.
Basabaeen AA; Abdelgader EA; Ahmed EB; Abdelateif NM; Osman Abdelrahim S; Sharif OM; Altayeb OA; Fadul EA; Osman Ibrahim I
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3229-3235. PubMed ID: 36172689
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 promoter -137 G/C polymorphism (rs187238) is associated with biochemical markers of renal function and cardiovascular disease in type 2 diabetes patients.
Cavalcante JEA; de Sousa ELH; de Oliveira Rodrigues R; de Almeida Viana G; Duarte Gadelha D; de Carvalho MMD; Sousa DL; Silva AJX; Filho RRBX; Fernandes VO; Montenegro Júnior RM; de Sousa Alves R; Meneses GC; Sampaio TL; Queiroz MGR
Clin Biochem; 2020 Jun; 80():1-7. PubMed ID: 32209332
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer.
Liu Y; Lin N; Huang L; Xu Q; Pang G
DNA Cell Biol; 2007 Aug; 26(8):613-8. PubMed ID: 17688413
[TBL] [Abstract][Full Text] [Related]
38. Lack of significant effect of interleukin-18 gene variants on tuberculosis susceptibility in the Polish population.
Wawrocki S; Kielnierowski G; Rudnicka W; Druszczynska M
Acta Biochim Pol; 2019 Jul; 66(3):337-342. PubMed ID: 31301271
[TBL] [Abstract][Full Text] [Related]
39. [Association of the tumor necrosis factor-alpha -1031T/C and its combination with interleukin-6 -634C/G gene polymorphisms with susceptibility to endometriosis].
Mao T; Zong LL; Wang YF; Zeng J; Fu YG; Zhao X; Rao XQ; Huang YX; Xu ZM; Zhu XN
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):328-32. PubMed ID: 22883518
[TBL] [Abstract][Full Text] [Related]
40. OGG1 rs1052133 Polymorphism and Genetic Susceptibility to Chronic Myelogenous Leukaemia.
Hassan FM
Asian Pac J Cancer Prev; 2019 Mar; 20(3):925-928. PubMed ID: 30912416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
